Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.
2 clinical trials · Sponsor
◉ Watch Shenzhen MingSight Relin Pharmaceuticals Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Study to Investigate the Efficacy and Safety of MS-553 in CLL/SLL (NCT05272813) | Shenzhen MingSight Relin Pharmaceuticals Co., Ltd. | 2022-04-28 |
| MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema (NCT04187443) | Shenzhen MingSight Relin Pharmaceuticals Co., Ltd. | 2020-06-02 |
Track Shenzhen MingSight Relin Pharmaceuticals Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.